Bristol Myers gets USFDA nod for new type of schizophrenia drug
- Posted on September 27, 2024
- By Financial Express
- 2 Views
Bristol Myers gets USFDA nod for new type of schizophrenia drug
Schizophrenia causes persistent delusions and hallucinations and significantly impairs the way patients perceive reality.
